Return to all milestones

Speeding up development through global collaboration

The WHO launches the 'Access to COVID-19 Tools Accelerator This link will open in a new window' to speed up the development and production of vaccines, diagnostics and therapeutics. The industry joins as a founding partner, determined to share its breadth of expertise with the scientific community.

Positive data on Gilead's antiviral treatment This link will open in a new window for COVID-19 emerges from a US NIAID study.

AstraZeneca and Oxford University sign a landmark agreement to develop a COVID-19 vaccine This link will open in a new window, enabling global development, manufacturing and distribution.

AstraZeneca This link will open in a new window also signs a deal with CEPI & Gavi to support the manufacturing, procurement and distribution of 300 million doses.